| References: |
NMDA receptor partial agonist that acts at the glycine site. Simultaneously acts as a promoter of the induction of long-term potentiation (LTP) and as a suppressor of long-term depression (LTD). Exhibits nootropic, neuroprotective and antinociceptive activity, and enhances learning, memory and cognition in vivo. Brain penetrant. For the detailed information of Rapastinel(GLYX-13), the solubility of Rapastinel(GLYX-13) in water, the solubility of Rapastinel(GLYX-13) in DMSO, the solubility of Rapastinel(GLYX-13) in PBS buffer, the animal experiment (test) of Rapastinel(GLYX-13), the cell expriment (test) of Rapastinel(GLYX-13), the in vivo, in vitro and clinical trial test of Rapastinel(GLYX-13), the EC50, IC50,and affinity,of Rapastinel(GLYX-13), For the detailed information of Rapastinel(GLYX-13), the solubility of Rapastinel(GLYX-13) in water, the solubility of Rapastinel(GLYX-13) in DMSO, the solubility of Rapastinel(GLYX-13) in PBS buffer, the animal experiment (test) of Rapastinel(GLYX-13), the cell expriment (test) of Rapastinel(GLYX-13), the in vivo, in vitro and clinical trial test of Rapastinel(GLYX-13), the EC50, IC50,and affinity,of Rapastinel(GLYX-13), Please contact DC Chemicals. |
